Filter your search
- $995.00 – $1,990.00The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles. In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. […]August 1, 2007$3,995.00 – $7,990.00The use of virtual reality (VR) technologies in the healthcare field is not simply a far-away future possibility. Technologies are already in place and the benefits from the application of VR are already evident in the healthcare domain. These applications provide doctors an opportunity to perform tasks in a risk-free environment, and make training accessible […]August 1, 2007$1,995.00 – $3,990.00The application of nutritional knowledge is an increasingly important part of the management and treatment of disease. Demographics and product development are expected to drive growth in the market for clinical nutrition. This Kalorama Information report – Clinical Nutrition Products: The World Market, represents the second time that Kalorama Information has taken a comprehensive look […]August 1, 2007$2,400.00 – $6,990.00Abundant opportunities are available for manufacturing companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost […]August 1, 2007$995.00 – $3,990.00In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough […]July 1, 2007$2,995.00 – $5,990.002008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information’s analyst Mary […]July 1, 2007$2,500.00 – $5,000.00An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues […]July 1, 2007$5,995.00 – $11,990.00This series provides total coverage of the Anti-Infectives market, a market that is changing due to product development resistance issues and in some cases, generic competition. Antifungals Antibacterials Antivirals As part of its comprehensive coverage, each report includes: Epidemiology including Incidence Statistics for each type of infection. Current Market Size and Revenue Forecasts for each […]July 1, 2007$1,995.00 – $7,990.00RFID (Radio Frequency IDentification) technologies are dramatically changing many industries, but as detailed in Kalorama’s market research report RFID Opportunities in Healthcare in the U.S., the greatest market for RFID is in healthcare. Hospitals, pharmaceutical companies, nursing homes, and other healthcare entities will benefit from using the technologies to keep track of inventories and patients. […]June 1, 2007$500.00 – $5,990.00Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although there is no cure, approved treatments are available to slow the progression of MS and offer improved quality of life. Kalorama Information’s: Multiple Sclerosis Treatments: World Market […]June 1, 2007
